UV-induced multifocal cutaneous high-grade leiomyosarcoma

Cutaneous sarcomas almost never present as multifocal disease. We describe a case of a man in his mid-90s with history of prior squamous cell carcinomas and an atypical fibroxanthoma involving the scalp who presented with multiple focal cutaneous nodules localised to the scalp, with some >3 cm. Biopsy with histopathology confirmed high-grade desmin-positive mesenchymal malignancy, with 99% of cells expressing PD-1, consistent with leiomyosarcoma (LMS). Gene expression profiling indicated a UV gene signature. The patient was treated with radiation therapy to the affected area with significant response but then developed additional cutaneous nodules inferior to the radiation field. He was subsequently treated with pembrolizumab with almost immediate resolution of the remaining nodules. This case is unique as it highlights several unusual features of cutaneous high-grade LMSs, notably presentation of multifocal disease, a UV signature and high responsiveness to anti-PD-1 therapy.

Authors

Institutions

Publication Details

Journal
BMJ Case Reports
Published
2025-04-01
DOI
https://doi.org/10.1136/bcr-2024-264326
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UV-induced multifocal cutaneous high-grade leiomyosarcoma

Bret Taback, Matthew Ehrlich, Igor Matushansky, Jacqueline Kloos
BMJ Case Reports
Sarcoma Diagnosis and Treatment
article

UV-induced multifocal cutaneous high-grade leiomyosarcoma

Bret Taback, Matthew Ehrlich, Igor Matushansky, Jacqueline Kloos
article en

Abstract

Cutaneous sarcomas almost never present as multifocal disease. We describe a case of a man in his mid-90s with history of prior squamous cell carcinomas and an atypical fibroxanthoma involving the scalp who presented with multiple focal cutaneous nodules localised to the scalp, with some >3 cm. Biopsy with histopathology confirmed high-grade desmin-positive mesenchymal malignancy, with 99% of cells expressing PD-1, consistent with leiomyosarcoma (LMS). Gene expression profiling indicated a UV gene signature. The patient was treated with radiation therapy to the affected area with significant response but then developed additional cutaneous nodules inferior to the radiation field. He was subsequently treated with pembrolizumab with almost immediate resolution of the remaining nodules. This case is unique as it highlights several unusual features of cutaneous high-grade LMSs, notably presentation of multifocal disease, a UV signature and high responsiveness to anti-PD-1 therapy.

BMJ Case ReportsVol. 18(4)
Columbia University Irving Medical Center (US), Texas Health Dallas (US), Columbia University (US)
Good health and well-being
Openalex Percentile: Top 88%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.